Increased arterial stiffness is closely associated with hyperglycemia and improved by glycemic control in diabetic

Junko Ibata1, Hideyuki Sasaki1, Tadashi Hanabusa1

  • 1First Department of Medicine Wakayama Medical University Wakayama Japan.

Insights

Hyperglycemia, a hallmark of diabetes mellitus (DM), significantly increases arterial stiffness, as measured by the cardio-ankle vascular index (CAVI). Glycemic control in DM patients demonstrably improves CAVI, highlighting its role as a sensitive marker for arteriosclerosis.

Area of Science:

  • Cardiovascular Medicine
  • Endocrinology
  • Vascular Biology

Background:

  • Arteriosclerotic diseases are common complications of diabetes mellitus (DM).
  • The precise relationship between hyperglycemia and arterial stiffness remains unclear.
  • The cardio-ankle vascular index (CAVI) offers a novel method for assessing arterial stiffness.

Purpose of the Study:

  • To investigate the impact of hyperglycemia on arterial stiffness using CAVI.
  • To determine the factors associated with elevated CAVI in early-stage DM.
  • To evaluate the effect of glycemic improvement on arterial stiffness in DM patients.

Main Methods:

  • Compared CAVI in 52 early-stage DM patients versus 43 age-matched non-diabetic (NDM) subjects.
  • Assessed the association between CAVI and clinical factors, including HbA1c, hypertension, obesity, and dyslipidemia.
  • Monitored changes in CAVI during a 2-week hospitalization for hyperglycemia treatment and at 8 weeks post-discharge in 36 DM patients.

Main Results:

  • DM patients exhibited significantly higher CAVI than NDM subjects.
  • Hemoglobin A1c (HbA1c) and age were significantly associated with elevated CAVI, independent of hypertension, obesity, or dyslipidemia.
  • Glycemic control led to significant improvements in CAVI and HbA1c, with CAVI improvement strongly correlating with HbA1c reduction.

Conclusions:

  • Elevated CAVI serves as a sensitive indicator of arteriosclerosis.
  • Arterial stiffness, as measured by CAVI, is closely linked to hyperglycemia.
  • Improving glycemic control in diabetic patients can effectively reduce arterial stiffness.
Abstract

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
Complications of Diabetes Mellitus01:22

Complications of Diabetes Mellitus

Diabetes mellitus is a chronic metabolic disorder characterized by persistent hyperglycemia due to insulin deficiency, resistance, or both. Prolonged hyperglycemia disrupts metabolic homeostasis and leads to acute and chronic complications.Acute ComplicationsAcute complications result from sudden metabolic imbalance.Diabetic ketoacidosis (DKA) mainly appears in type 1 diabetes but may also develop in type 2 diabetes, particularly under extreme stress. It arises from severe insulin deficiency,...
Hyperglycemia01:29

Hyperglycemia

Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose levels exceed 180 mg/dL two...
Diabetic Nephropathy01:28

Diabetic Nephropathy

Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...
Diabetic Neuropathy01:22

Diabetic Neuropathy

DefinitionDiabetic neuropathy is nerve damage caused by long-standing diabetes mellitus. It results directly from prolonged high blood sugar levels.PathophysiologyThe pathophysiology of diabetic neuropathy involves both metabolic and vascular disturbances triggered by chronic hyperglycemia.Metabolic injury: Elevated glucose levels activate the polyol pathway within nerve cells, leading to the accumulation of sorbitol and fructose. This increases oxidative stress, disrupts normal nerve...